[Deep sclerectomy for the management of uveitic glaucoma].
OBJECTIVE
To report middle-term results of deep sclerectomy in uveitis patients with glaucoma who are resistant to medical therapy.


METHODS
Eight eyes of eight patients (mean age, 56.9 years; range, 46-67 years) with uveitic glaucoma resistant to medical therapy underwent deep sclerectomy without antimetabolites between 1994 and 2001. All patients had their uveitis controlled before and after surgery by anti-inflammatory therapy.


RESULTS
Mean follow-up was 42.2 months. Intraocular pressure was reduced from a mean preoperative value of 32.3 mmHg to a mean postoperative value of 15.2 (52.9% reduction). Success was obtained in seven eyes (87.5%). It was complete in four eyes (57.2%) and relative in three eyes (42.8%). Failure was noted in one eye (12.5%), controlled later by trabeculectomy. Antiglaucomatous medication was reduced from a mean of 2.9 medications preoperatively to 0.6 medications (79.3% reduction). Postoperative complications included one case of lens opacity and one case of hyphema.


CONCLUSIONS
The low rate of surgical complications and the lack of failure risk factors except inflammation and long-term use of antiglaucomatous medication may explain the high success rate of deep sclerectomy in this study.
Souissi
K
K
Service d'Ophtalmologie, Centre Hospitalo-Universitaire Habib Thameur, Tunis, Tunisia. souissikhal@yahoo.fr
El Afrit
M A
MA
Trojet
S
S
Kraiem
A
A
D000368:Aged; D005260:Female; D005901:Glaucoma / Q000209:etiology* / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012590:Sclera / Q000601:surgery*; D014130:Trabeculectomy; D014605:Uveitis / Q000150:complications* / Q000601:surgery*